VIVUS (VVUS) Resumes Trading +17%
Tweet
Share
E-mailGet Alerts VVUS Hot Sheet
Join SI Premium – FREE
Share of VIVUS Inc. (Nasdaq: VVUS) resume trading up 17% after the FDA approved obesity drug Qsymia.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UGI Corp. (UGI) halted on volatility, up 6%
- Kenon Holdings (KEN) halted, news pending
- Planet Green halted again, now up 793%
Create E-mail Alert Related Categories
FDA, Momentum Movers, Trader Talk, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
